Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-15 4:32 pm Purchase |
2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS |
RA Capital Management, L.P. | 957,624 7.500% |
957,624 (New Position) |
Filing History |
| 2021-02-16 07:33 am Sale |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Altium Capital Management LLC | 41,667 1.200% |
-112,500 (-72.97%) |
Filing History |
| 2021-02-16 06:26 am Sale |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Corriente Advisors LLC | 0 0.000% |
-134,097 (Position Closed) |
Filing History |
| 2021-02-12 1:14 pm Unchanged |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,417 7.570% |
0 (Unchanged) |
Filing History |
| 2021-02-08 5:15 pm Purchase |
2021-01-28 | 13D | Astria Therapeutics, Inc. ATXS |
Perceptive Advisors LLC | 412,821 10.500% |
412,821 (New Position) |
Filing History |
| 2021-02-02 3:16 pm Purchase |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
194,464 5.800% |
194,464 (New Position) |
Filing History |
| 2020-11-10 1:53 pm Sale |
2020-10-31 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,417 7.570% |
-93,383 (-26.39%) |
Filing History |